Abstract: The present invention relates to pharmaceutical compositions comprising polyoxyethylene glycol, fatty acid mono- and diglyceride ester as an absorption promoting agent and an absorption controlling agent together with a therapeutically, prophylactically and/or diagnostically active substance. The pharmaceutical compositions are especially suitable for mucosal administration such as intranasal administration.
Type:
Grant
Filed:
July 29, 2002
Date of Patent:
February 15, 2005
Assignee:
Lyfjathroun hf.
Inventors:
Sveinbjorn Gizurarson, Sigridur Olafsdottir, Jakob Lindal Kristinsson, Kolbrun Hrafnkelsdottir, David Rurik Olafsson, Oddur Ingolfsson, Ellen Ruth Ingimundardottir
Abstract: The present invention relates to pharmaceutical compositions comprising polyoxyethylene glycol, fatty acid mono- and diglyceride ester as an absorption promoting agent and an absorption controlling agent together with a therapeutically, prophylactically and/or diagnostically active substance. The pharmaceutical compositions are especially suitable for mucosal administration such as intranasal administration.
Type:
Application
Filed:
July 29, 2002
Publication date:
January 8, 2004
Applicant:
Lyfjathroun hf.
Inventors:
Sveinbjorn Gizurarson, Sigridur Olafsdottir, Jakob Lindal Kristinsson, Kolbrun Hrafnkelsdottir, David Rurik Olafsson, Oddur Ingolfsson, Ellen Ruth Ingimundardottir